The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
KisoJi Biotechnology
Laval, Canada
A
1-10 Employees
2009
Key takeaway
KisoJi is a pioneering next-generation antibody company that specializes in developing multi-specific antibodies to tackle challenging targets in oncology and other diseases. Their innovative platform, which includes single domain antibodies and advanced antibody fingerprinting technology, enables the identification and optimization of lead candidates with enhanced potency and specificity.
Reference
Core business
Home | KisoJi Biotechnology
KisoJi is a leading next-generation antibody company developing multi-specific antibodies to address difficult targets in oncology and other diseases
Abdera Therapeutics
Vancouver, Canada
A
1-10 Employees
2021
Key takeaway
The company, Abdera Therapeutics, is focused on innovative science and developing optimized therapies for cancer, leveraging a team with extensive experience in biologics and drug development. Their advanced antibody engineering platform may be particularly relevant to the exploration of bispecific antibodies in cancer treatment.
Reference
Product
Platform • Abdera
Designed Biologics
Ottawa, Canada
A
- Employees
-
Key takeaway
Designed Biologics specializes in developing small peptides with tailored targeting properties, utilizing a computational platform that enables the creation of nano IgG-like specific antibodies. Their innovative approach allows for rapid and precise design, making it well-suited for addressing multiple protein targets.
Reference
Core business
DesignedBiologics - Designing the future of medicine
We use AI to design peptides with custom targeting properties for therapeutics
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Zymeworks
Vancouver, Canada
A
101-250 Employees
2004
Key takeaway
Zymeworks is focused on developing innovative therapies for difficult-to-treat cancers, including the engineered bispecific antibody zanidatamab, which targets HER2 using their proprietary Azymetric™ technology. This approach highlights Zymeworks' commitment to advancing bispecific antibody development through strategic partnerships and a robust pipeline.
Reference
Product
T Cell Engagers — Zymeworks
Utilizing Azymetric™ to build differentiated and next generation T Cell Engagers
Aspect Biosystems
Vancouver, Canada
A
11-50 Employees
2013
Key takeaway
Aspect Biosystems is a Canadian biotechnology company focused on pioneering a new category of regenerative medicine through the development of bioprinted tissue therapeutics. Their innovative approach aims to transform disease treatment, which may align with advancements in bispecific antibody technology.
Reference
Core business
Aspect Biosystems | Bioprinting Tissue Therapeutics
Developing bioprinted tissue therapeutics to transform how we treat disease.
Biodextris
Laval, Canada
A
11-50 Employees
2014
Key takeaway
Biodextris specializes in the development, manufacturing, and testing of a wide range of biologic products, including antibodies. With their extensive experience in the biologics field, they provide technical and quality guidance to help navigate the regulatory path for innovative products.
Reference
Core business
Biodextris | Bringing Innovation to Life
La/le Scientifique analytique I utilise ses connaissances professionnelles ainsi que les politiques et procédures de l’entreprise pour exécuter des tâches et résoudre divers problèmes au sein du département analytique.
Biomatik Corporation
Cambridge, Canada
A
11-50 Employees
2002
Key takeaway
Biomatik specializes in providing a wide range of life science products and services, including over 14,000 antibodies, which may encompass bispecific antibodies. Their commitment to quality and innovative research supports the needs of the drug discovery community.
Reference
Core business
Biomatik - Integrated Life Science Products & Services
Alpha Cancer Technologies
Old Toronto, Canada
A
11-50 Employees
2008
Key takeaway
The company's drug products utilize their proprietary recombinant human alpha fetoprotein (AFP), which possesses unique immuno-oncology properties. This highlights their focus on innovative therapeutic solutions in the field of oncology, relevant to bispecific antibody development.
Reference
Product
Our Products - Alpha Cancer Technologies
The company’s drug products use our proprietary recombinant human alpha fetoprotein (AFP) with unique immuno-oncology properties.
BioGlobaX Inc.
Old Toronto, Canada
A
1-10 Employees
2013
Key takeaway
BioGlobaX is a Canadian biotechnology consulting firm that specializes in preclinical drug discovery, particularly in biopharmaceuticals. With over 25 years of experience, they provide customized services and resources to enhance the development of life sciences products.
Reference
Core business
ABOUT US - BioGlobaX 200-100 Consilium Place Toronto Canada
BioGlobaX is a Canadian biotechnology consulting firm that helps in quality improvement of products and services and cost reduction by the adoption of QbD.
Amgen British Columbia Inc
Burnaby, Canada
A
11-50 Employees
1993
Key takeaway
Amgen is a leader in developing biologic medicines through advanced molecular biology, which includes a focus on innovative protein therapeutics for serious illnesses like cancer. Their commitment to drug discovery and a robust pipeline positions them to explore various therapeutic modalities.
Reference
Core business
Amgen Biosimilars | Amgen Canada
Technologies which have been searched by others and may be interesting for you:
In the Bispecific Antibody industry in Canada, several key considerations are essential for anyone researching companies in this field. Regulatory frameworks play a significant role, as Health Canada oversees the approval and monitoring of biopharmaceuticals. Understanding the processes for clinical trials and product approvals is crucial, as these can differ from other regions. The competitive landscape is also noteworthy; Canada hosts a mix of established companies and innovative startups, which can impact market dynamics and collaboration opportunities. Moreover, challenges such as high development costs and the complexities of manufacturing bispecific antibodies must be considered. However, the industry presents substantial opportunities, particularly in cancer therapy and autoimmune diseases, where bispecific antibodies can enhance treatment efficacy. Environmental concerns regarding biotechnology practices are increasingly relevant, necessitating awareness of sustainable practices within the industry. Additionally, the global market for bispecific antibodies is expanding, with Canadian companies often participating in international collaborations, which can amplify their reach and potential impact. Keeping abreast of trends, technological advancements, and partnerships will provide valuable insights for individuals interested in this promising sector.
Some interesting numbers and facts about your company results for Bispecific Antibody
| Country with most fitting companies | Canada |
| Amount of fitting manufacturers | 126 |
| Amount of suitable service providers | 82 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1993 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Bispecific Antibody
What are related technologies to Bispecific Antibody?
Based on our calculations related technologies to Bispecific Antibody are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Bispecific Antibody?
Start-Ups who are working in Bispecific Antibody are Abdera Therapeutics
Which industries are mostly working on Bispecific Antibody?
The most represented industries which are working in Bispecific Antibody are Biotechnology, Other, Pharmaceuticals, IT, Software and Services, Healthcare
How does ensun find these Bispecific Antibody Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
